Yuhan Corporation (KRX:000100)
South Korea · Delayed Price · Currency is KRW 83,700
-1,200 (-1.41%)
At close: Aug 31, 2026
Yuhan Market Cap
Yuhan has a market cap or net worth of 6.24 trillion as of August 31, 2026. Its market cap has decreased by -26.50% in one year.
Market Cap
6.24T
Enterprise Value
6.23T
Revenue
2.28T
Ranking
n/a
PE Ratio
26.66
Stock Price
83,700.00
ChartMarket Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 6.24T, an increase of 2,593.80%. That is a compound annual growth rate of 13.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 6.24T | -25.60% |
| Dec 30, 2025 | 8.39T | -6.18% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 6.46T |
| Hanall Biopharma | 3.28T |
| Celltrion Pharm | 1.88T |
| GC Biopharma | 1.49T |
| Daewoong Pharmaceutical | 1.48T |
| Chong Kun Dang Pharmaceutical | 902.56B |
| Boryung | 766.24B |
| Daewoong | 756.24B |